Rhythm Biosciences Ltd has released a press release.
RHY Executes SE Asian Genetype Distribution Agreement
Earlier from Rhythm Biosciences
- Exercise of RHYO Options underwritten for $4.5m to $6.0m
- Trading Halt
- Half-Year Financial Report and Appendix 4D
- Rhythm Bio enters ColoSTAT agreement with 4Cyte Pathology